SCIEX Diagnostics

Why do Mass Spectrometers need to be Medical Devices?

Clinical biochemistry laboratories face many daily challenges, including managing high sample workloads, managing clinician requests for novel tests, and generating and reporting out results in a…

Citrine MS/MS – your Medical Diagnostic mass spectrometer

In the modern diagnostic lab, analytical challenges demand increased sensitivity, speed, robustness and reliability of any diagnostic system, and mass spectrometry is no different. Designed and…

Article • Heroin, fentanyl, carfentanyl

Mass Spec detects illicit drugs

As a synthetic opioid approved for treating severe pain, fentanyl has shown clear medical benefits. However, in recent years, continuous abuse of fentanyl and its derived analogues substances has…

Interview • Liquid chromatography-mass spectrometry

Increasing productivity and throughput in the lab

Liquid chromatography-mass spectrometry (LC-MS) has become a highly valued procedure in state-of-the-art laboratories – among them the Dr. Wisplinghoff Laboratory in Cologne, which adopted the…

News • Laboratory

SCIEX mass spectrometry platforms get new algorithms

SCIEX announced a new release of its LC and mass spectrometry operating system, SCIEX OS software, which provides new tools for full regulatory compliance and updated calculation algorithms that…

A New Chapter for Clinical Lab LC-MS/MS Systems

Every day you’re challenged to deliver faster, reliable results to inform clinicians. Now the power of LC-MS/MS technology is available with the Topaz™ System from SCIEX, developed with the…

News • Clinical diagnostics

SCIEX launches high-performance mass spectrometry technology

SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced the launch of the Citrine Triple Quad MS/MS and Citrine…

News • Mass spectrometry

SCIEX announces first FDA-cleared Vitamin D assay kit

SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced the first and only FDA-cleared (via the de novo pathway)…

News • Scientific event

Record-breaking number of visitors for the SCIEX LC-MS/MS Symposium

SCIEX, a global leader in life science analytical technologies, hosted the 7th Berliner LC-MS/ MS Symposium, which took place from 13th-15th March 2017 at the Estrel Hotel in Berlin. The Symposium…

Article • Prostate Cancer

Proteomic mass spectrometry

Scientists at a UK university are using the power of mass spectrometry to research critical processes in human prostate cancer.

News • Donation

SCIEX Supports Vital Cancer Prevention Research

SCIEX’s donation to the WCRF following several significant research partnerships with world-leading cancer scientists to advance the promise of Precision Medicine.

News • SCIEX QTRAP 6500 LC-MS/MS

System demonstrates sensitivity in method development

SCIEX announced today that Aarhus University Hospital in Denmark has invested in SCIEX QTRAP 6500 technology to develop novel mass spectrometry-based assays for clinical research laboratories.…

News •

Moving mass spec into the clinical lab

Mass spectrometry has been applied in advanced clinical research and drug discovery and development. Continual innovations have created capabilities to address complex analytical challenges…

Sponsored • Clinical lab equipment